Table 3.8. Number and rates* of deaths with hepatitis C virus infection listed as a cause of death† among residents, by demographic characteristics — United States, 2015–2019
Characteristics | 2015 No. | 2015 Rate* (95% CI) |
2016 No. | 2016 Rate* (95% CI) |
2017 No. | 2017 Rate* (95% CI) |
2018 No. | 2018 Rate* (95% CI) |
2019 No. | 2019 Rate* (95% CI) |
---|---|---|---|---|---|---|---|---|---|---|
Total | 19,566 | 4.91 (4.84-4.98) |
18,093 | 4.42 (4.36-4.49) |
17,253 | 4.13 (4.07-4.20) |
15,713 | 3.72 (3.66-3.78) |
14,242 | 3.33 (3.28-3.39) |
Age (yrs) | ||||||||||
0-34 | 196 | 0.13 (0.11-0.15) |
164 | 0.11 (0.09-0.13) |
180 | 0.12 (0.10-0.14) |
212 | 0.14 (0.12-0.16) |
170 | 0.11 (0.10-0.13) |
35-44 | 592 | 1.46 (1.34-1.58) |
532 | 1.31 (1.20-1.43) |
507 | 1.24 (1.13-1.35) |
499 | 1.21 (1.10-1.31) |
472 | 1.13 (1.03-1.24) |
44-54 | 3,659 | 8.47 (8.20-8.75) |
3,026 | 7.07 (6.82-7.32) |
2,556 | 6.03 (5.80-6.27) |
2,040 | 4.90 (4.69-5.11) |
1,676 | 4.10 (3.90-4.30) |
55-64 | 9,678 | 23.68 (23.20-24.15) |
9,011 | 21.73 (21.28-22.18) |
8,275 | 19.70 (19.28-20.13) |
7,297 | 17.26 (16.87-17.66) |
6,304 | 14.85 (14.48-15.22) |
65-74 | 4,009 | 14.55 (14.10-15.00) |
4,071 | 14.22 (13.78-14.66) |
4,397 | 14.81 (14.38-15.25) |
4,429 | 14.52 (14.10-14.95) |
4,499 | 14.29 (13.87-14.71) |
≥75 | 1,431 | 7.08 (6.71-7.45) |
1,288 | 6.25 (5.91-6.59) |
1,329 | 6.28 (5.94-6.61) |
1,235 | 5.63 (5.32-5.94) |
1,117 | 4.95 (4.66-5.24) |
Sex | ||||||||||
Male | 14,043 | 7.27 (7.15-7.40) |
12,815 | 6.48 (6.36-6.59) |
12,287 | 6.12 (6.01-6.23) |
11,242 | 5.53 (5.42-5.63) |
10,229 | 4.96 (4.86-5.05) |
Female | 5,523 | 2.71 (2.63-2.78) |
5,278 | 2.54 (2.47-2.61) |
4,966 | 2.32 (2.26-2.39) |
4,471 | 2.09 (2.02-2.15) |
4,013 | 1.83 (1.77-1.89) |
Race/ethnicity | ||||||||||
White, non-Hispanic | 12,329 | 4.35 (4.27-4.43) |
11,389 | 3.95 (3.88-4.03) |
10,781 | 3.70 (3.63-3.78) |
9,858 | 3.35 (3.28-3.42) |
9,056 | 3.08 (3.01-3.14) |
Black, non-Hispanic | 3,602 | 8.13 (7.86-8.40) |
3,360 | 7.42 (7.16-7.68) |
3,262 | 7.03 (6.79-7.28) |
2,978 | 6.31 (6.08-6.54) |
2,646 | 5.44 (5.23-5.65) |
Hispanic | 2,737 | 6.48 (6.23-6.74) |
2,510 | 5.76 (5.53-6.00) |
2,399 | 5.29 (5.08-5.51) |
2,190 | 4.64 (4.44-4.84) |
1,865 | 3.84 (3.66-4.02) |
Asian/Pacific Islander | 415 | 2.32 (2.09-2.55) |
384 | 2.03 (1.82-2.24) |
368 | 1.86 (1.67-2.05) |
300 | 1.43 (1.27-1.60) |
308 | 1.43 (1.27-1.59) |
American Indian/Alaska Native | 324 | 11.45 (10.18-12.73) |
285 | 9.80 (8.63-10.97) |
299 | 10.24 (9.04-11.44) |
264 | 9.05 (7.93-10.17) |
259 | 8.63 (7.55-9.72) |
HHS Region: Regional Office ¶ | ||||||||||
Region 1: Boston | 732 | 3.78 (3.50-4.07) |
616 | 3.1 (2.85-3.35) |
602 | 2.97 (2.72-3.21) |
519 | 2.56 (2.33-2.79) |
448 | 2.15 (1.94-2.36) |
Region 2: New York | 1,379 | 3.78 (3.58-3.98) |
1,167 | 3.12 (2.94-3.30) |
1,043 | 2.76 (2.59-2.93) |
924 | 2.48 (2.31-2.64) |
780 | 2.06 (1.91-2.21) |
Region 3: Philadelphia | 1,675 | 4.17 (3.96-4.37) |
1,478 | 3.68 (3.48-3.87) |
1,441 | 3.53 (3.35-3.72) |
1,253 | 3.04 (2.87-3.22) |
1,185 | 2.85 (2.68-3.02) |
Region 4: Atlanta | 3,703 | 4.53 (4.38-4.68) |
3,500 | 4.18 (4.03-4.32) |
3,450 | 4.03 (3.89-4.16) |
3,160 | 3.60 (3.47-3.72) |
2,996 | 3.36 (3.24-3.49) |
Region 5: Chicago | 2,182 | 3.24 (3.11-3.38) |
2,064 | 3.01 (2.88-3.15) |
1,846 | 2.63 (2.51-2.75) |
1,762 | 2.52 (2.40-2.64) |
1,611 | 2.27 (2.15-2.38) |
Region 6: Dallas | 3,280 | 7.08 (6.83-7.33) |
3,194 | 6.69 (6.45-6.92) |
3,169 | 6.54 (6.31-6.77) |
2,907 | 5.85 (5.64-6.07) |
2,562 | 5.06 (4.86-5.25) |
Region 7: Kansas City | 623 | 3.58 (3.29-3.87) |
593 | 3.31 (3.04-3.59) |
589 | 3.24 (2.97-3.51) |
544 | 3.04 (2.78-3.30) |
496 | 2.67 (2.43-2.92) |
Region 8: Denver | 634 | 4.67 (4.30-5.04) |
640 | 4.69 (4.32-5.06) |
615 | 4.38 (4.02-4.73) |
636 | 4.45 (4.09-4.80) |
600 | 4.10 (3.77-4.44) |
Region 9: San Francisco | 4,053 | 6.84 (6.63-7.05) |
3,668 | 6.08 (5.88-6.28) |
3,330 | 5.37 (5.19-5.56) |
2,928 | 4.63 (4.46-4.80) |
2,564 | 4.00 (3.84-4.15) |
Region 10: Seattle | 1,305 | 7.49 (7.08-7.91) |
1,173 | 6.56 (6.17-6.94) |
1,168 | 6.38 (6.01-6.76) |
1,080 | 5.79 (5.43-6.14) |
1,000 | 5.27 (4.94-5.61) |
* Rates for race/ethnicity, sex, HHS region, and the overall total are age-adjusted per 100,000 US standard population during 2000 by using the following age group distribution (in years): <1, 1–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84, and ≥85. Missing data are not included. For age-adjusted death rates, the age-specific death rate is rounded to 1 decimal place before proceeding to the next step in the calculation of age-adjusted death rates for NCHS Multiple Cause of Death on CDC WONDER. This rounding step might affect the precision of rates calculated for small numbers of deaths.
† Cause of death is defined as 1 of the multiple causes of death and is based on the International Classification of Diseases, 10th Rev. (ICD-10) codes B17.1, and B18.2 (hepatitis C).
¶ US Department of Health and Human Services (HHS) regions were categorized according to the grouping of states and US territories assigned under each of the 10 HHS regional offices (https://www.hhs.gov/about/agencies/iea/regional-offices/index.html). For the purposes of this report, regions with US territories (Region 2 and Region 9) contain data from states only
This table summarizes the characteristics of hepatitis C-associated deaths among residents in the United States. During 2019, a total of 14,242 hepatitis C-associated deaths were reported among US residents in the US Multiple Cause of Death data from the National Center for Health Statistics, resulting in an age-adjusted mortality rate of 3.33 deaths per 100,000 population. Mortality rates were highest among persons aged 55–74 years, compared with other age categories, and deaths in this age group accounted for 76% of all hepatitis C-associated deaths reported during 2019. Non-Hispanic White persons accounted for 64% of all hepatitis C-associated deaths; however, the mortality rates among American Indian/Alaska Native persons and non-Hispanic Black persons were 2.8 times and 1.8 times, respectively, the mortality rate among non-Hispanic White persons. The highest hepatitis C-associated mortality rate was reported in Health and Human Services Region 10 (Alaska, Idaho, Oregon, and Washington), compared with other regions. Region-specific mortality rates have been consistently decreasing each year since 2015 for all regions except Health and Human Services Region 8 (Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming), which has had the lowest overall decrease in hepatitis C-associated mortality rate since 2015.
- Figure 3.1. Number of reported acute hepatitis C virus infection cases and estimated infections — United States, 2012–2019
- Figure 3.2. Rates of reported acute hepatitis C virus infections, by state — United States, 2018–2019
- Figure 3.3. Rates of reported acute hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Figure 3.4. Rates of reported acute hepatitis C virus infection, by age group — United States, 2004–2019
- Figure 3.5. Rates of reported acute hepatitis C virus infection, by sex — United States, 2004–2019
- Figure 3.6. Rates of reported acute hepatitis C virus infection, by race/ethnicity — United States, 2004–2019
- Figure 3.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2019
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases, by sex and age — United States, 2019
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 3.1. Number and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2015–2019
- Table 3.2. Number and rates of reported cases of acute hepatitis C, by demographic characteristics — United States 2015–2019
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2019
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.5. Number and rates of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.6. Number and rates of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2019
- Table 3.7. Number and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 3.8. Number and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019